The weekly litigation news digest is live. Subscribe now

IP Verse

Nucleic Acid Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd) - EP3192880

The patent EP3192880 was granted to Fred Hutchinson Cancer Research Center on Oct 9, 2019. The application was filed on Aug 18, 2011 under application number EP16191567A. The patent is currently recorded with a legal status of "Revoked".

EP3192880

FRED HUTCHINSON CANCER RESEARCH CENTER
Application Number
EP16191567A
Filing Date
Aug 18, 2011
Status
Revoked
May 20, 2022
Publication Date
Oct 9, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
STRAWMANJul 8, 2020MEWBURN ELLISADMISSIBLE
REDDIE & GROSEJul 7, 2020CARRIDGEADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONFR2422956
DESCRIPTIONUS4376110
OPPOSITIONEP2426203
OPPOSITIONWO2013016352
SEARCHEP2426203
SEARCHUS2009280517
SEARCHWO2005037231
SEARCHWO2013016352
SEARCHWO2013019623

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents